Learn more

NANJING SAIERJIAN BIOTECHNOLOGY CO LTD

Overview
  • Total Patents
    17
  • GoodIP Patent Rank
    96,735
About

NANJING SAIERJIAN BIOTECHNOLOGY CO LTD has a total of 17 patent applications. Its first patent ever was published in 2019. It filed its patents most often in China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are AH USA 42 LLC, MEDIGENE AG and ORBSEN THERAPEUTICS LTD.

Patent filings in countries

World map showing NANJING SAIERJIAN BIOTECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 17

Patent filings per year

Chart showing NANJING SAIERJIAN BIOTECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Yu Haitao 17
#2 Yang Xiaoxu 16
#3 Li Tao 5
#4 Li Xiang 1

Latest patents

Publication Filing date Title
CN111803496A Use of xanthocapone alkali for treating endometrial cancer
CN111777692A Rubus parvifolius graded polysaccharide, preparation method and application in depression resistance
CN111643507A Application of fernasenol in treating pulmonary fibrosis
CN111743903A Application of taraxacil in treating pulmonary fibrosis
CN111743909A Use of smilacin A for treating rhabdomyosarcoma
CN111718399A Polypeptide and application of polypeptide in NK cell culture and preparation of NK cell culture medium
CN111620932A Polypeptide and application thereof in promoting NK cell proliferation and improving lethality of NK cell to tumor cells
CN111721874A HPLC method for separating tadalafil and chiral isomer thereof
CN111721873A Method for separating dihydromyricetin and (2S,3S) chiral isomer thereof based on reversed-phase HPLC
CN111419836A Use of 12 α -methoxy-germacrane-triene-12, 6 α -acetal for anti-human glioma
CN111419837A Use of 12 α -methoxy-germacrane-triene-12, 6 α -acetal for anti-human rhabdomyosarcoma
CN111329855A Use of 12 α -methoxy-germacrane-triene-12, 6 α -acetal for resisting human breast cancer
CN111518759A Application of (S) -3-thiomorpholine formic acid in promoting proliferation of umbilical cord mesenchymal stem cells and umbilical cord mesenchymal stem cell culture medium
CN111450096A Application of phosphorylation inhibitor of STAT3 in preparation of medicine for resisting acute myeloid leukemia
CN111529531A STAT3 phosphorylation inhibitor and application thereof in preparing medicine for treating acute myeloid leukemia
CN110981840A Method for purifying michelia lactone from magnolia liliiflora leaves
CN110755419A Application of Holly magnolia alcohol A or B in preparation of medicine for treating knee osteoarthritis